505 related articles for article (PubMed ID: 4369281)
1. The diagnosis and management of myasthenia gravis.
Walsh JC
Med J Aust; 1974 Jun; 1(25):997-1001. PubMed ID: 4369281
[No Abstract] [Full Text] [Related]
2. Treatment of myasthenia--I.
Br Med J; 1971 Apr; 2(5754):160-2. PubMed ID: 4325739
[No Abstract] [Full Text] [Related]
3. [Myasthenia gravis pseudoparalytica. Clinical picture, pathogenesis, therapy].
Kunze K
Med Klin; 1973 Jun; 68(22):723-30. PubMed ID: 4715780
[No Abstract] [Full Text] [Related]
4. [Pseudoparalytic myasthenia gravis. Diagnostic and therapeutic aspects in 60 separate cases].
Mumenthaler M; Lütschg J
Schweiz Arch Neurol Neurochir Psychiatr; 1976; 118(1):23-56. PubMed ID: 981976
[TBL] [Abstract][Full Text] [Related]
5. [Behavioral of evoked potentials in repeated stimulation of the facial nerve and electromyographic diagnosis of myasthenia gravis].
Bassi S; Crespi V; Passerini D; Smirne S
Riv Neurol; 1975; 45(1):60-3. PubMed ID: 167419
[No Abstract] [Full Text] [Related]
6. [On the treatment of myasthenia].
Delwaide JP
Rev Med Liege; 1968 Sep; 23(18):552-7. PubMed ID: 4316587
[No Abstract] [Full Text] [Related]
7. [Current therapy of myasthenia gravis. I. Specific symptomatic therapy].
Erbslöh F
Nervenarzt; 1972 Jul; 43(7):341-4. PubMed ID: 4627866
[No Abstract] [Full Text] [Related]
8. Myasthenia gravis with features of the myasthenic syndrome. An investigation with electrophysiologic methods including single-fiber electromyography.
Schwartz MS; Stålberg E
Neurology; 1975 Jan; 25(1):80-4. PubMed ID: 1167410
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and treatment of ocular myasthenia (author's transl)].
Huber A
Klin Monbl Augenheilkd; 1977 Dec; 171(6):889-95. PubMed ID: 203742
[TBL] [Abstract][Full Text] [Related]
10. Myasthenia gravis lacking response to cholinergic drugs.
Black JT; Brait KA; DeJesus PV; Harner RN; Rowland LP
Neurology; 1973 Aug; 23(8):851-3. PubMed ID: 4352602
[No Abstract] [Full Text] [Related]
11. Incrementing responses in myasthenia gravis.
Mayer RF; Williams IR
Arch Neurol; 1974 Jul; 31(1):24-6. PubMed ID: 4365402
[No Abstract] [Full Text] [Related]
12. Single fibre EMG in juvenile myasthenia gravis.
Stalberg E; Hansson O
Neuropadiatrie; 1973 Jan; 4(1):20-9. PubMed ID: 4349293
[No Abstract] [Full Text] [Related]
13. [Drug therapy in myasthenia gravis].
Aarli JA
Tidsskr Nor Laegeforen; 1976 Dec; 96(34-36):1803-5. PubMed ID: 189451
[No Abstract] [Full Text] [Related]
14. [Therapy of myasthenia gravis in pregnancy].
Pezzoli G; Bonfadini Bossi E; Rella R
Minerva Ginecol; 1980; 32(1-2):21-6. PubMed ID: 6245392
[No Abstract] [Full Text] [Related]
15. Neurogenic muscle atrophy in myasthenia gravis.
Brownell B; Oppenheimer DR; Spalding JM
J Neurol Neurosurg Psychiatry; 1972 Jun; 35(3):311-22. PubMed ID: 4338443
[TBL] [Abstract][Full Text] [Related]
16. Essentials in the management of myasthenia gravis.
Galdi AP
Am Fam Physician; 1978 Jun; 17(6):95-102. PubMed ID: 655080
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic enhancement of neuromuscular transmission in myasthenia gravis.
Riggs JE
Clin Neuropharmacol; 1982; 5(3):277-92. PubMed ID: 6288236
[No Abstract] [Full Text] [Related]
18. [Therapy of pseudoparalytic myasthenia gravis].
Fasshauer K
Dtsch Med Wochenschr; 1975 Oct; 100(44):2283-4. PubMed ID: 1183327
[No Abstract] [Full Text] [Related]
19. The Eaton-Lambert syndrome in ocular myasthenia gravis.
Oh SJ
Arch Neurol; 1974 Sep; 31(3):183-6. PubMed ID: 4855164
[No Abstract] [Full Text] [Related]
20. [Myasthenia gravis in an active 48-year-old woman, demonstrated clinically, electrically and serologically, well tolerated for 30 years, thanks to Prostigmine and Mestinon. Some theoretical and practical problems].
Chesni Y
Rev Med Suisse Romande; 1979 May; 99(5):289-90. PubMed ID: 119291
[No Abstract] [Full Text] [Related]
[Next] [New Search]
